Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Neven

Showing results (101-110 of 383) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age relatedPatrick Neven, Nathalie Pochet, Maria Drijkoningen, et al.
Breast Cancer Research and Treatment|April 11, 2014
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical studyGilbert Donders, Patrick Neven, Maximilian Moegele, et al.
European Journal of Radiology|December 13, 2021
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriersHadeel Ghunaim, Annouschka Laenen, Frederik De Keyzer, et al.
BMJ (Clinical Research Ed.)|September 3, 2011
Effect of manual lymph drainage in addition to guidelines and exercise therapy on arm lymphoedema related to breast cancer: randomised controlled trialNele Devoogdt, Marie-Rose Christiaens, Inge Geraerts, et al.
Gynecologic Oncology|October 22, 2008
Wilms' tumor gene 1 (WT1) in endometrial carcinomaAn Coosemans, Philippe Moerman, Godelieve Verbist, et al.
Journal of the National Cancer Institute|May 22, 2023
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish Observational Cohort StudyJosephine Van Cauwenberge, Kristien Borremans, Maxime Van Houdt, et al.
JNCI Cancer Spectrum|June 27, 2023
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differencesStephen Johnston, Anna Emde, Carlos Barrios, et al.
Annals of Medicine and Surgery (2012)|May 25, 2023
Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort studyJolien Jansen, Eva Oldenburger, Jente Jansen, et al.
Neoplasia (New York, N.Y.)|May 5, 2019
Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian CancerEls Van Nieuwenhuysen, Pieter Busschaert, Annouschka Laenen, et al.
The Lancet. Oncology|March 1, 2008
Are gene signatures better than traditional clinical factors?Patrick Neven, Vanya Van Belle, Olivier Brouckaert, et al.
Pageof 39

Showing results (101-110 of 383) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age relatedPatrick Neven, Nathalie Pochet, Maria Drijkoningen, et al.
Breast Cancer Research and Treatment|April 11, 2014
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical studyGilbert Donders, Patrick Neven, Maximilian Moegele, et al.
European Journal of Radiology|December 13, 2021
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriersHadeel Ghunaim, Annouschka Laenen, Frederik De Keyzer, et al.
BMJ (Clinical Research Ed.)|September 3, 2011
Effect of manual lymph drainage in addition to guidelines and exercise therapy on arm lymphoedema related to breast cancer: randomised controlled trialNele Devoogdt, Marie-Rose Christiaens, Inge Geraerts, et al.
Gynecologic Oncology|October 22, 2008
Wilms' tumor gene 1 (WT1) in endometrial carcinomaAn Coosemans, Philippe Moerman, Godelieve Verbist, et al.
Journal of the National Cancer Institute|May 22, 2023
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish Observational Cohort StudyJosephine Van Cauwenberge, Kristien Borremans, Maxime Van Houdt, et al.
JNCI Cancer Spectrum|June 27, 2023
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differencesStephen Johnston, Anna Emde, Carlos Barrios, et al.
Annals of Medicine and Surgery (2012)|May 25, 2023
Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort studyJolien Jansen, Eva Oldenburger, Jente Jansen, et al.
Neoplasia (New York, N.Y.)|May 5, 2019
Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian CancerEls Van Nieuwenhuysen, Pieter Busschaert, Annouschka Laenen, et al.
The Lancet. Oncology|March 1, 2008
Are gene signatures better than traditional clinical factors?Patrick Neven, Vanya Van Belle, Olivier Brouckaert, et al.
Pageof 39